| A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening D Shattuck-Eidens, M McClure, J Simard, F Labrie, S Narod, F Couch, ... Jama 273 (7), 535-541, 1995 | 596 | 1995 |
| Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides M Boyd, SC Ross, J Dorrens, NE Fullerton, KW Tan, MR Zalutsky, ... Journal of nuclear medicine 47 (6), 1007-1015, 2006 | 200 | 2006 |
| A human BRCA1 gene knockout M Boyd, F Harris, R McFarlane, HR Davidson, DM Black Nature 375 (6532), 541-542, 1995 | 126 | 1995 |
| The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cells C Rae, M Tesson, JW Babich, M Boyd, A Sorensen, RJ Mairs Journal of Nuclear Medicine 54 (6), 953-960, 2013 | 104 | 2013 |
| Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine M Boyd, SH Cunningham, MM Brown, RJ Mairs, TE Wheldon Gene therapy 6 (6), 1147-1152, 1999 | 98 | 1999 |
| Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models S Carlin, SH Cunningham, M Boyd, AG McCluskey, RJ Mairs Cancer gene therapy 7 (12), 1529-1536, 2000 | 83 | 2000 |
| Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution JA Barrett, JL Joyal, SM Hillier, KP Maresca, FJ Femia, JF Kronauge, ... Cancer biotherapy & radiopharmaceuticals 25 (3), 299-308, 2010 | 82 | 2010 |
| Deletion of the dual specific phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP kinase phosphatase-2 (MKP-2) in proliferation and cell survival A Lawan, S Al-Harthi, L Cadalbert, AG McCluskey, M Shweash, G Grassia, ... Journal of Biological Chemistry 286 (15), 12933-12943, 2011 | 77 | 2011 |
| Emulsion technologies for multicellular tumour spheroid radiation assays KS McMillan, AG McCluskey, A Sorensen, M Boyd, M Zagnoni Analyst 141 (1), 100-110, 2016 | 75 | 2016 |
| An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation‐mediated bystander effects M Boyd, RJ Mairs, WN Keith, SC Ross, P Welsh, G Akabani, J Owens, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2004 | 71 | 2004 |
| Microsatellite analysis for determination of the mutagenicity of extremely low-frequency electromagnetic fields and ionising radiation in vitro RJ Mairs, K Hughes, S Fitzsimmons, KM Prise, A Livingstone, L Wilson, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 626 (1-2 …, 2007 | 70 | 2007 |
| Focused very high-energy electron beams as a novel radiotherapy modality for producing high-dose volumetric elements K Kokurewicz, E Brunetti, GH Welsh, SM Wiggins, M Boyd, A Sorensen, ... Scientific Reports 9 (1), 10837, 2019 | 68 | 2019 |
| Synthesis and evaluation of a radioiodinated tracer with specificity for poly (ADP-ribose) polymerase-1 (PARP-1) in vivo F Zmuda, G Malviya, A Blair, M Boyd, AJ Chalmers, A Sutherland, ... Journal of Medicinal Chemistry 58 (21), 8683-8693, 2015 | 66 | 2015 |
| New Sulphated Flavonoids from Wissadula periplocifolia (L.) C. Presl (Malvaceae) YCF Teles, CCR Horta, MF Agra, W Siheri, M Boyd, JO Igoli, AI Gray, ... Molecules 20 (11), 20161-20172, 2015 | 63 | 2015 |
| Preclinical Evaluation of an 131I-Labeled Benzamide for Targeted Radiotherapy of Metastatic Melanoma JL Joyal, JA Barrett, JC Marquis, J Chen, SM Hillier, KP Maresca, M Boyd, ... Cancer research 70 (10), 4045-4053, 2010 | 57 | 2010 |
| Dosimetry of very high energy electrons (VHEE) for radiotherapy applications: using radiochromic film measurements and Monte Carlo simulations A Subiel, V Moskvin, GH Welsh, S Cipiccia, D Reboredo, P Evans, ... Physics in Medicine & Biology 59 (19), 5811, 2014 | 56 | 2014 |
| Radiation quality‐dependent bystander effects elicited by targeted radionuclides M Boyd, A Sorensen, AG McCluskey, RJ Mairs Journal of Pharmacy and Pharmacology 60 (8), 951-958, 2008 | 56 | 2008 |
| [131I]meta-Iodobenzylguanidine and Topotecan Combination Treatment of Tumors Expressing the Noradrenaline Transporter AG McCluskey, M Boyd, SC Ross, E Cosimo, AM Clark, WJ Angerson, ... Clinical cancer research 11 (21), 7929-7937, 2005 | 55 | 2005 |
| Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy M Boyd, SC Mairs, K Stevenson, A Livingstone, AM Clark, SC Ross, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2002 | 53 | 2002 |
| Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I] MIBG and clonogenic cell kill M Boyd, RJ Mairs, SC Mairs, L Wilson, A Livingstone, SH Cunningham, ... Oncogene 20 (53), 7804-7808, 2001 | 52 | 2001 |
Robert MairsInstitute of Cancer Sciences, Glasgow UniversityVerified email at glasgow.ac.uk
